ProfileGDS4459 / ENSG00000108599
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 60% 67% 63% 32% 75% 77% 60% 70% 65% 62% 74% 67% 68% 44% 63% 35% 64% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.7760
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.0667
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.9763
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.9132
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.6775
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.7977
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.8960
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.3970
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.0665
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.9562
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.5274
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.2267
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.2268
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.2344
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.9663
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.9135
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.8964